Posted: 28 July 2022
Submissions close on Friday 16 September 2022.
Join us in celebration of our life science leaders who are championing the sector throughout Australia and the global community.
Each year, the AusBiotech and Johnson & Johnson Innovation Industry Excellence Awards are presented at the AusBiotech national conference to recognise the highest achievers in the Australian life sciences. From researchers who successfully translate their discoveries to clinical practice, to companies who pioneer the developments of new treatments and reliable diagnostics, these prestigious Awards recognise the leading lights of Australia’s world-class biotechnology, medical technology and healthcare sectors.
Nominations are welcome which address the key selection criteria for the applicable entry category, along with 400 words outlining why the nominated individual/ company/ institute/ association/ organisation should be awarded the 2022 AusBiotech and Johnson & Johnson Innovation Industry Excellence Award.
All applicants must be headquartered in Australia. Organisations with existing commercial interests owned by Johnson & Johnson or subsidiaries of Johnson & Johnson are not eligible. Staff/ Board members and their associated organisations of Johnson & Johnson and AusBiotech are not eligible.
More information available here.